Monte Rosa Therapeutics, Inc. GLUE Change in Lease Liabilities
Change in Lease Liabilities at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monte Rosa Therapeutics, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monte Rosa Therapeutics, Inc.'s change in lease liabilities?
- Monte Rosa Therapeutics, Inc. (GLUE) reported change in lease liabilities of -$434K in Q1 2026.
- How has Monte Rosa Therapeutics, Inc.'s change in lease liabilities changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s change in lease liabilities decreased by 53.4% year-over-year, from -$283K to -$434K.
- What is the long-term trend for Monte Rosa Therapeutics, Inc.'s change in lease liabilities?
- Over 2 years (2023 to 2025), Monte Rosa Therapeutics, Inc.'s change in lease liabilities has grown at a -67.7% compound annual growth rate (CAGR), from $10.37M to -$1.08M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.